Inmune Bio, Inc. (INMB): auditor change — INmune Bio dismisses Marcum as auditor, engages CBIZ CPAs due to acquisition

Inmune Bio, Inc.

Dismissed Marcum LLP on May 7, 2025, following acquisition of its attest business by CBIZ CPAs P.C.
Audit committee approved engagement of CBIZ CPAs as new independent registered public accounting firm for fiscal 2025.
No disagreements or reportable events during 2024, 2023, or through May 7, 2025.
Prior audit report included going concern explanatory paragraph (substantial doubt about ability to continue as going concern).

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Inmune Bio, Inc. dismissed Marcum LLP as its auditor.

Action: dismissal
Auditor: Marcum LLP
Successor: CBIZ CPAs P.C.

Exact text from the filing

On May 7, 2025, INmune Bio Inc. (the “Company”) dismissed Marcum as the Company’s independent registered public accounting firm as a result of such acquisition, and the Company’s audit committee approved the dismissal.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Inmune Bio, Inc. engaged CBIZ CPAs P.C. as its auditor.

Action: engagement
Auditor: CBIZ CPAs P.C.

Exact text from the filing

On May 7, 2025, with the approval of the Company’s audit committee, CBIZ CPAs was engaged as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2025.

View on SEC.gov

Browse all auditor changes →

Inmune Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-040727

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.